Danish industry pleads device cause:
This article was originally published in Clinica
An organogram of Denmark's new Medicines Agency makes no mention of medical devices, despite the fact that device regulation will be the responsibility of the pharmacotherapeutic secretariat. The Danish Medical Device Association (DMDA) says it hopes the importance of devices will be upgraded in the new organisation (see Clinica No 746, p 2). On May 1st, the DMDA was due to meet Ib Bo Lumholtz, who took over as director of the Medicines Agency on March 1st, to discuss the allocation of resources to the device area.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.